entertainment -WSS

entertainment

author：explore 2025-09-29 01:35:03 - browse：5587

A follow-up study of a first-of-its-kind cancer treatment may reflect systemic biases, the Food and Drug Administration said ahead of an advisory committee meeting Thursday to determine whether the drug should remain on the market.

The treatment, Lumakras, is designed to treat lung cancer caused by a specific genetic mutation to a protein called KRAS. It’s one of the most common genetic mutations in cancer, but repeated clinical trial failures had led researchers to deem it “undruggable” until a glimmer of hope came about a decade ago.

Lumakras received an accelerated, or conditional, approval in May 2021, making it the first KRAS drug on the market. Now, the drug’s manufacturer, Amgen, needs to prove it works.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： A clever new way to fix Medicaid and graduate medical education

hotspot

entertainment

WSS

California man arrested in connection with serial murders of Mexican strip club workers

Drinking water from half of US faucets contains PFAS: Study

Excited delirium, Elijah McClain, and emergency physicians

The PBM ad wars are taking over Washington, D.C.

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

More doctors should go into startup world

hotspot

entertainment

explore

What does generative AI mean for health care? We asked experts

White House calls on federal agencies to crack down on AI abuses

Supreme Court strikes down use of affirmative action

A clever new way to fix Medicaid and graduate medical education

Cancer drug shortages should be causing more outrage

UCSF medical school apologizes for unethical prisoner experiments

Drug repurposing or repositioning? The language matters

Just how powerful is the placebo effect?

Wildfire smoke exposes gaps in outdoor worker protections

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

entertainment

Senate panel clears PBM, hopsital reforms

How redistricting in 6 states could affect who controls Congress

Will General Catalyst be the first of many hospital takeovers?

Rare Northern Lights show in US this week: Where and how to see it

Medicare solvency divides Republicans at the presidential debate

HPV cancer vaccine study demonstrates efficacy

hotspot

entertainment

hotspot

focus